Local Regulatory Experts
Connect with regulatory affairs consultancies specializing in this region.
Qualtech Consulting Corporation
Taiwan, China, Japan, Singapore, Hong Kong, Malaysia, Philippines, Vietnam, Australia, Germany, Korea, Thailand, USA
A specialized medical device consulting firm offering a one-stop solution for complex global regulatory challenges. We offer real-time regulatory and clinical support, local representation, and QMS services across 13 markets, ensuring efficient market entry and compliance.
Registrar Corp
Hampton, Virginia (HQ), Shenzhen, China, London, United Kingdom, Paris, France, Madrid, Spain, Hyderabad, India, Kuala Lumpur, Malaysia, Tel Aviv, Israel, Guatemala City, Guatemala, Cape Town, South Africa
A global FDA compliance firm assisting businesses in the food, medical device, drug, and cosmetic industries with registration, U.S. Agent services, labeling, and regulatory software solutions.
ARQon Pte. Ltd.
Singapore (HQ), Malaysia, Vietnam, Indonesia, Philippines, Thailand, Taiwan, Hong Kong, South Korea, Switzerland, USA, Australia, New Zealand, Rwanda, India, Sri Lanka
We are a premier regulatory consultancy firm specializing in medical devices, in-vitro diagnostics (IVD), and pharmaceuticals. Founded in 2014, the company offers a comprehensive suite of services ranging from product development strategy and clinical trials to product registration and post-market surveillance. With a team of experts possessing vast experience in regulatory authorities and industry, we bridge the gap between scientific innovation and regulatory compliance, ensuring patient safety while fostering medical advancement. The company also provides unique business matching services through its ATTOPOLIS platform and training through the International Medical Device School.
EPSI GLOBAL PTE. LTD.
Singapore (HQ), Kuala Lumpur, Malaysia, Jakarta, Indonesia, Bangkok, Thailand, Hanoi, Vietnam, Manila, Philippines, Shanghai, China
We provide end-to-end regulatory solutions covering all classes of medical devices and IVDs in major APAC markets, especially the ASEAN region (Singapore, Malaysia, Indonesia, Thailand, Vietnam, Philippines) and major Northeast Asian markets (China, Korea, Japan). Services include classification, registration, local authorized representation, quality management system (QMS) implementation/auditing (ISO 13485/local GMP), and post-market surveillance. Their local presence minimizes market entry risks and time-to-market.
September 16, 2025
Approximately 5 minutes
Medical Device Grouping in Malaysia: Streamlining Registration via the ASEAN MDD Framework
Medical Device Grouping in Malaysia: Streamlining Registration via the ASEAN MDD Framework
The Malaysian Medical Device Authority (MDA) provides guidance on medical device Grouping to simplify the registration process for manufacturers. Grouping allows multiple related product variants to be submitted under a single registration application, offering a more cost-effective and time-saving approach. This guidance is harmonized with the ASEAN Medical Devices Directive (AMDD).
Core Grouping Rules
All accepted grouping categories in Malaysia are centered on three basic rules that must be met for a single application:
- One generic proprietary name.
- One manufacturer.
- One common intended purpose.
Accepted Grouping Categories
The MDA recognizes six main categories for grouping applications:
- Single: A single medical device that may vary only in package size and/or number of units, while still complying with the three core rules.
- Family: Products that share a common risk classification, manufacturer, generic proprietary name, intended use, design, and manufacturing process. They are permitted to differ only slightly from each other through Permissible Variants.
- System: A combination of accessories and a medical device that work together to achieve a common intended purpose. The labeling and Instructions for Use (IFU) must indicate that the devices are intended to be sold as a system.
- Set: A collection of two or more medical devices (potentially from different manufacturers) imported and sold in the same packaging with the same intended purpose, under the same proprietary set name. The risk classification is determined by the device with the highest risk.
- IVD Test Kit: Contains reagents and/or articles meant to be used in combination for a common intended purpose. They must have a common manufacturer and a single proprietary name. (Excludes analyzers).
- IVD Cluster: Contains in-vitro reagents and/or articles from a common manufacturer and shares a common test methodology, but may have different intended uses. These articles must be restricted to risk classification A or B.
Permissible Variants for 'Family' Grouping
The Family grouping allows for specific variations between products within the group that do not fundamentally change the device's safety or efficacy. These permissible variants include, but are not limited to:
- Physical Properties: Color, diameter, length, size, shape, volume, width, and flexibility.
- Technical Specifications: Gauge, isotope activity level, memory storage, print capability, and radiopacity.
- Material: Viscosity (if the change is only due to concentration of constituent material).
- Design: Type of device mounting (e.g., wall mount, ceiling mount) and dimensional design differences for pediatric versus adult use.
- Product-Specific Examples: For catheters, permissible variants include the number of lumens and material (e.g., PVC, silicone); for contact lenses, diopter, UV protection, and tinting are permissible variants.
Related Articles
Approximately 5 minutes
Medical Device Registration in Malaysia: MDA Requirements, ASEAN Alignment, and Reliance Pathways
Medical device registration in Malaysia is mandatory, managed by the **Medical Device Authority (MDA)**, and requires a local **Malaysia Authorized Holder (MAH)** to submit via the **MEDCAST** system. Classification follows **AMDD/GHTF** (Classes A-D), with faster review times (6-8 weeks for Class A; 3-6 months for others) and provisional registration granted under the **Fast Track System** based on **Reference Country** approvals.
Approximately 5 minutes
IVD Product Registration in Malaysia: MDA Oversight, Fast Track, and ISO 13485 Mandate
In Vitro Diagnostic (IVD) product registration in Malaysia is managed by the **Medical Device Authority (MDA)** and requires a local **Authorized Representative** to submit via the **MEDCAST** system. **Class A** devices (non-measuring, non-sterile) are exempt. Other classes are eligible for a **Fast Track Provisional Registration** (up to 5 years) based on **Reference Country** approval, while all must document quality compliance with **ISO 13485**.
Approximately 5 minutes
Medical Device Classification in Malaysia: Risk-Based System and AMDD Alignment
Malaysia’s Medical Device Authority (MDA) classifies devices into risk categories **A, B, C, and D** (low to high), plus a separate **Combination Device** class, based on the **ASEAN Medical Devices Directive (AMDD)**. Classification is determined by factors like intended use, duration of contact, invasiveness, and local vs. systemic effects, with more documentation required as risk increases.
Approximately 5 minutes
Mandatory Medical Device Labeling Requirements in Malaysia: Language, Content, and MDA Guidance
Medical device labeling in Malaysia is regulated by the **MDA's Guidance Document** and must contain key information like the **Malaysian registration number** and the **Authorized Representative's** details. All labels must be in **English**, and products for home use require instructions in both **English and Bahasa Malaysia**. Manufacturers are encouraged to use **QR codes** for registration numbers. Devices for export only are exempted if marked as 'export only'.
Approximately 5 minutes
Maintaining Medical Device Registration in Malaysia: The Change Notification (CN) Process
In Malaysia, maintaining a medical device license requires the license holder to report all changes via the **Change Notification (CN)** process through the **MedC@st 2.0** portal. Changes are categorized into three types: **Category 1** (requires new registration for major changes), **Category 2** (requires MDA endorsement for moderate changes), and **Category 3** (minor administrative changes that can be implemented immediately with notification).
Approximately 5 minutes
Post-Market Surveillance and Adverse Event Reporting in Malaysia: MDA Vigilance Requirements
The MDA mandates Post-Market Surveillance (PMS) for medical devices in Malaysia, requiring manufacturers to report Adverse Events (AEs) within strict timelines: **48 hours** for public health threats, **10 days** for death/serious deterioration, and **30 days** for potential serious injury recurrence. The **Malaysia Authorized Representative** is responsible for communicating all post-market vigilance to the MDA.